Lack of covalent binding of peroxisome proliferators nafenopin and WY-14 643 to DNA in vivo and in vitro
- 31 December 1984
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 24 (1) , 37-43
- https://doi.org/10.1016/0378-4274(85)90137-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to HumansCRC Critical Reviews in Toxicology, 1983
- Phthalate esters as peroxisome proliferator carcinogens.Environmental Health Perspectives, 1982
- HEPATIC AND RENAL EFFECTS OF PEROXISOME PROLIFERATORS: BIOLOGICAL IMPLICATIONS*Annals of the New York Academy of Sciences, 1982
- Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to manFood and Cosmetics Toxicology, 1981
- Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14, 643) in the semipurified dietCarcinogenesis: Integrative Cancer Research, 1981
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980
- Malignant Tumors in Rats Fed Nafenopin, a Hepatic Peroxisome Proliferator 2JNCI Journal of the National Cancer Institute, 1977
- Hepatic Peroxisome Proliferation: Induction by Two Novel Compounds Structurally Unrelated to ClofibrateScience, 1975
- RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT, ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB)The Journal of cell biology, 1966
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965